Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012856 |
---|---|
Receipt number | R000015024 |
Scientific Title | A Phase II trial of SOX plus bevacizumab or cetuximab as neoadjuvant chemotherapy in patients with locally advanced rectal cancer (OITA-trial II) |
Date of disclosure of the study information | 2014/01/15 |
Last modified on | 2019/03/16 13:16:29 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/01/15 16:15:14 | ||
2 | Update | 2014/01/20 18:16:06 | Key secondary outcomes |
|
3 | Update | 2019/03/16 13:16:29 | Recruitment status Date of IRB Last follow-up date |